The U.S. Food and Drug Administration (FDA) has announced new protocols for COVID-19 vaccinations.
In an announcement about the new “simplified” vaccination guidelines, the FDA quietly revealed that the monovalent Pfizer and Modena mRNA Covid shots “are no longer authorized for use in the United States.”
The change was revealed in a press release published on Tuesday.
The decision was made through a recent amendment to the Emergency Use Authorizations of the pharmaceutical companies’ Covid bivalent vaccines.
In the amendment, the FDA ruled the bivalent Moderna and Pfizer Covid-19 vaccines will be used for all doses.
Subsequently, monovalent doses, which targeted the original strain, will no longer be authorized.
The FDA claims the decision was made in order to “simplify” the vaccine process.
However, many people who have already received the monovalent Covid shots are questioning why the FDA is making the decision now.
Today, FDA amended the EUAs of the Pfizer-BioNTech and Moderna COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. https://t.co/Cd74KB3n9p
What you need to know. 🧵👇 pic.twitter.com/9394LP1HvR— U.S. FDA (@US_FDA) April 18, 2023
Most individuals, depending on age, previously vaccinated with a monovalent COVID-19 vaccine who have not yet received a dose of a bivalent vaccine may receive a single dose of a bivalent vaccine.
— U.S. FDA (@US_FDA) April 18, 2023
Per The FDA:
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations.
The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
Most individuals, depending on age, previously vaccinated with a monovalent COVID-19 vaccine who have not yet received a dose of a bivalent vaccine may receive a single dose of a bivalent vaccine.
Most individuals who have already received a single dose of the bivalent vaccine are not currently eligible for another dose.
The FDA intends to make decisions about future vaccination after receiving recommendations on the fall strain composition at an FDA advisory committee in June.
The announcement provoked a fierce backlash on Twitter.
Many responded with outrage and accused the FDA of “tricking” people into taking the shots before they quietly withdrew authorization.
The @US_FDA can pound sand. We will NEVER TRUST YOU AGAIN. Not only that, we will move mountains to make sure you are held accountable for what you have done.
— 🧐In a Tin Hat Tizzy🇺🇸 (@ActivateStrong) April 19, 2023
The sudden decision also caught the attention of James O’Keefe.
The Project Veritas founder is now asking FDA whistleblowers to come forward.
Can someone from the FDA please tell me what’s going on here? OKeefeTips@protonmail.com https://t.co/YfyLeJyWNn
— James O'Keefe (@JamesOKeefeIII) April 18, 2023
READ MORE: Fully Vaxxed Lose 25 Years of Life Expectancy, Study Shows
